Joann Peters

Joann Peters

Company: Geneos Therapeutics, Inc.

Job title: Chief Operating Officer

Seminars:

Roundtable Discussion: Defining Quality Control Strategies That Support Speed, Compliance & Global Trial Execution for Personalized Vaccines 9:30 am

• Defining scalable QC frameworks for PCVs by identifying which release assays reduce redundancy, batch release time, and regulatory rework at Phase II and beyond • Applying risk-based release strategies in bespoke manufacturing workflows to enable faster, compliant release of low-volume batches • Designing digital QA systems early on to support faster QP release as…Read more

day: Pre-Conference Manufacturing Focus Day

Roundtable: Determining Optimal Duration of Cancer Vaccine Therapy to Maximize Immune Durability, Minimize Patient Burden, & Improve Long- Term Outcomes 3:00 pm

• How to define the right length of vaccine administration in advanced and adjuvant settings to maximize durable immune responses and reduce relapse risk • How to weigh the trade-offs between prolonged treatment and patient quality of life to avoid unnecessary long-term psychological burden • How to tailor duration strategies by modality (RNA, DNA, peptides)…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.